Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
Kim, T. D., Turkmen, S., Schwarz, M., Koca, G., Nogai, H., Bommer, C., Dorken, B., Daniel, P., le Coutre, P.Volume:
95
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2009.014712
Date:
April, 2010
File:
PDF, 428 KB
english, 2010